Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 7,439 shares at $690.00 ($5.1M) on 2022-03-21, disclosed to the SEC on 2022-03-23.
Open-market sale of $5.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |